SOMERSET THERAPEUTICS LLC 2025-12-24 Health moderate FDA
Health · FDA · Recall #FDA-D-0238-2026
Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose… Recall
Issued December 24, 2025 · SOMERSET THERAPEUTICS LLC
In December 2025, SOMERSET THERAPEUTICS LLC recalled the Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose…, a moderate health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Subpotent product:out of specification assay results observed during long term stability testing.
What you should do
- 1 Stop using Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact SOMERSET THERAPEUTICS LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- SOMERSET THERAPEUTICS LLC
- Category
- Health
- Recall date
- December 24, 2025
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0238-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- SOMERSET THERAPEUTICS LLC has 2 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.